Reference is hereby made to the statements on Schedule 13D originally filed with the Securities and Exchange Commission on March 31, 2000, as amended pursuant to Amendment No. 1 dated June 15, 2000, Amendment No. 2 dated November 9, 2000, Amendment No. 3 dated September 18, 2001, Amendment No. 4 dated October 15, 2002, Amendment No. 5 dated June 5, 2006, Amendment No. 6 dated January 30, 2007, Amendment No. 7 dated June 11, 2007, Amendment No. 8 dated October 23, 2008, Amendment No. 9 dated July 22, 2009, Amendment No. 10 dated October 8, 2009, Amendment No. 11 dated March 4, 2010, Amendment No. 12 dated April 16, 2010, Amendment No. 13 dated March 9, 2011, Amendment No. 14 dated May 14, 2015, Amendment No. 15 dated August 17, 2017 and Amendment No. 16 dated April 1, 2019 (collectively, the Schedule 13D) which are incorporated by reference. Pursuant to this Amendment No. 17 to Schedule 13D, Item 5 of Schedule 13D is hereby amended as follows:
Item 5. Interest in Securities of the Issuer.
(a) As of the date hereof, the Reporting Person beneficially owns the amount of Common Stock set forth below. The percentage set forth below is based upon 3,648,753 shares of Common Stock outstanding on January 17, 2020.
Shares of
Common Stock
|
|
Percentage of Outstanding
Common Stock
|
|
67,437
|
|
1.8%
|
|
(b) The Reporting Person has the sole power to vote and dispose of the shares of Common Stock, which he beneficially owns.
(c) During the past sixty (60) days, the Reporting Person sold 299,075 shares of Common Stock to the Company pursuant to a public tender offer by the Company at a price of $163.00 per share.
(d) Not applicable.
(e) As of the date hereof, the Reporting Person ceased to be the beneficial owner of more than 5% of the Common Stock of the Company.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
No change.
Item 7. Material to be Filed as Exhibits.
None.
3